Claims
- 1. A pharmaceutical tablet comprising 6.55 mg alendronate monosodium trihydrate, 110.45 mg anhydrous lactose, 80.0 mg microcrystalline cellulose, 1.00 mg magnesium stearate, and 2.00 mg croscarmellose sodium.
CROSS REFERENCE TO RELATED APPLICATIONS
This is a continuation of U.S. Ser. No. 09/432,859, filed Nov. 2, 1999 now Pat. No. 6,194,004, which in turn is a continuation of U.S. Ser. No. 09/141,782, filed Aug. 28, 1998, now U.S. Pat. No. 6,090,410, issued Jul. 18, 2000, which in turn is a continuation of U.S. Ser. No. 08/946,849, filed Oct. 8, 1997, now U.S. Pat. 5,882,656, issued Mar. 16, 1999, which in turn is a continuation of U.S. Ser. No. 08/454,100, filed Jul. 26, 1995, now U.S. Pat. No. 5,681,590, issued Oct. 28, 1997, which in turn is a U.S. National Phase Application of International Patent Application No. PCT/US93/11172, filed Nov. 17, 1993, which is a continuation of U.S. Ser. No. 984,399, filed Dec. 2, 1992, now U.S. Pat. No. 5,358,941, issued Oct. 25, 1994.
US Referenced Citations (22)
Foreign Referenced Citations (12)
Number |
Date |
Country |
0 252 504 |
Jan 1988 |
EP |
0 275 468 |
Jul 1988 |
EP |
0 282 320 |
Sep 1988 |
EP |
0 402 152 |
Jun 1989 |
EP |
0 325 482 |
Jul 1989 |
EP |
0 449 405 |
Oct 1991 |
EP |
0 511 767 |
Nov 1992 |
EP |
1036368 |
Jul 1966 |
GB |
1 435 885 |
May 1976 |
GB |
WO 8800829 |
Feb 1988 |
WO |
WO 9211269 |
Jul 1992 |
WO |
WO 9321907 |
Nov 1993 |
WO |
Non-Patent Literature Citations (12)
Entry |
Physician's Desk Reference, 44th ed., (1990), p. 1534, “Didronel (etidronate disodium)”. |
Lachman et al., The Theory and Practice of Industrial Pharmacy, 3rd ed., (1986), p. 326. |
Remington's Pharmaceutical Science. 15th ed., Mack Pub. Co., Easton, PA, pp. 1586-1588. |
Pharm. Dosage Forms -Tablets, 2nd ed., Eds. Lieberman et al., Marcel Dekker Inc., NY, NY (1989), pp. 97-98, “Tablet formulation and design”. |
Pharm. Dosage Forms -Tablets, 2nd ed., Eds. Lieberman et al., Marcel Dekker Inc., NY, NY (1989), pp. 195-246, Compressed tablets by direct compression″. |
Handbook of Pharm. Excipients, The Pharmaceutical Society of Great Britain, London (1986), pp. 153-162, “Lactose”. |
Encyc. of Pharm. Techn., Eds. Swarbrick et al., Marcel Dekker Inc., NY, NY (1991), pp. 85-99, “Direct compression tableting”. |
Encyc. of Pharm. Techn., Eds. Swarbrick et al., Marcel Dekker Inc., NY, NY (1988), pp. 451-464, “Binders”. |
Technica Farma. e Farmacia Galenica, 3rd ed., vol. 1, Eds. Nogueira Prista et al., Fundacao Calouste Bulbenkian, Lisboa, Portugal (1983), pp. 780-795 and 802-803 -English translation. |
Henderson et al., J. Pharm. Sci., vol. 59(9), pp. 1336-1370 (1970), “Lactose USP (Beadlets) and dextrose (PAF 2011): Two agents for direct compression”. |
Shangraw et al., Pharm. Tech. (Sept. 1981), pp. 69-78, “Morphology and funtionality in tablet excipients for direct compression: part I”. |
Shangraw et al., Pharm. Tech. (Oct. 1981), pp. 44-60, “Morphology and functionality in tablet excipients for direct compression: part II”. |
Continuations (5)
|
Number |
Date |
Country |
Parent |
09/432859 |
Nov 1999 |
US |
Child |
09/690540 |
|
US |
Parent |
09/141782 |
Aug 1998 |
US |
Child |
09/432859 |
|
US |
Parent |
08/946849 |
Oct 1997 |
US |
Child |
09/141782 |
|
US |
Parent |
08/454100 |
|
US |
Child |
08/946849 |
|
US |
Parent |
07/984399 |
Dec 1992 |
US |
Child |
09/432859 |
Nov 1999 |
US |